Mrv1909 12031923222D 17 18 0 0 0 0 999 V2000 -0.8473 -0.1689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5618 -0.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0937 -0.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7611 0.6515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.2763 -0.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5619 -1.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4583 0.1085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0776 -1.3115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0458 0.8230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9908 -0.5813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2764 -1.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2787 0.0221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3814 1.5766 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.9908 -1.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7637 0.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5842 0.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0691 1.2707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 2 5 2 0 0 0 0 2 6 1 0 0 0 0 3 7 1 0 0 0 0 3 8 2 0 0 0 0 4 9 1 0 0 0 0 5 10 1 0 0 0 0 6 11 2 0 0 0 0 7 12 1 0 0 0 0 9 13 2 0 0 0 0 10 14 2 0 0 0 0 12 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 7 9 1 0 0 0 0 11 14 1 0 0 0 0 M END > DB13629 > drugbank > CCCCC1C(=O)NN(C1=O)C1=CC=CC=C1 > InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16) > REOJLIXKJWXUGB-UHFFFAOYSA-N > C13H16N2O2 > 232.283 > 232.121177763 > 2 > 33 > 25.472060926797937 > 1 > 1 > 0 > 1 > 4-butyl-1-phenylpyrazolidine-3,5-dione > 1.57 > 2.2541632513333334 > -2.26 > 0 > 2 > -1 > 10.778673443698908 > 5.609008966096487 > 49.410000000000004 > 64.084 > 4 > 1 > 1.27e+00 g/l > (2S)-2-amino-4-[(2-ethanimidamidoethyl)sulfanyl]butanoic acid > 0 > DB13629 > experimental > Mofebutazone > Mofebutazona; Mofebutazone; Mofebutazonum $$$$